We demonstrated that, in contrast to classical opioid receptors, ACKR3 does not result in classical G protein signaling and isn't modulated from the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we established that LIH383, an ACKR3-selective subnanomolar https://russellv692cxs1.theobloggers.com/profile